| A549 | Human lung adenocarcinoma cell line |
| AKT | Protein kinase B |
| AKT1 | AKT serine/threonine kinase 1 |
| As | Arsenic |
| ATSDR | Agency for Toxic Substances and Disease Registry |
| BAD | BCL2-associated agonist of cell death |
| BAX | BCL2-associated X protein |
| BCL2 | B-cell lymphoma 2 |
| BEAS-2B | Human bronchial epithelial cell line |
| c-IAP2 | Cellular inhibitor of apoptosis protein 2 |
| CAT | Catalase |
| CCNB1 | Cyclin B1 |
| Cd | Cadmium |
| Cl1-0 | Human lung invasive cancer cell line |
| Cr(VI) | Hexavalent chromium |
| CTD | Comparative Toxicogenomics Database |
| DNA | Deoxyribonucleic acid |
| EGFR | Epidermal growth factor receptor |
| ERK1/2 | Extracellular signal-regulated kinase 1/2 |
| ErbB | ErbB family of receptor tyrosine kinases |
| FAK | Focal adhesion kinase |
| FOS | Fos proto-oncogene |
| G:C | Guanine:cytosine |
| T:A | Thymine:adenine |
| GPX1 | Glutathione peroxidase 1 |
| GPX3 | Glutathione peroxidase 3 |
| GSTM1 | Glutathione S-transferase Mu 1 |
| H125 | Human lung cancer cell line |
| HIF-1 | Hypoxia-inducible factor 1 |
| HIF-1α | Hypoxia-inducible factor 1 alpha |
| HIF1A | Hypoxia-inducible factor 1 subunit alpha |
| HMOX1 | Heme oxygenase 1 |
| IARC | International Agency for Research on Cancer |
| IFNG | Interferon gamma |
| IL1B | Interleukin 1 beta |
| IL4 | Interleukin 4 |
| IL6 | Interleukin 6 |
| IL13 | Interleukin 13 |
| Integrin β3 | Integrin beta 3 |
| JAK | Janus kinase |
| JNK | c-Jun N-terminal kinase |
| KRAS | KRAS proto-oncogene |
| MAPK | Mitogen-activated protein kinase |
| MAPK1 | Mitogen-activated protein kinase 1 |
| MAPK3 | Mitogen-activated protein kinase 3 |
| MeHgCl | Methylmercury chloride |
| MMC | Methylmercury compounds |
| mRNA | Messenger ribonucleic acid |
| mTOR | Mechanistic target of rapamycin |
| MSP | Macrophage-stimulating protein |
| MTOR | Mechanistic target of rapamycin kinase |
| MyD88 | Myeloid differentiation primary response protein 88 |
| NF-κB | Nuclear factor kappa B |
| Ni | Nickel |
| NNK | 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone |
| NOS2 | Nitric oxide synthase 2 |
| NQO1 | NAD(P)H quinone dehydrogenase 1 |
| NSCLC | Non-small-cell lung cancer |
| OGG1 | 8-Oxoguanine DNA glycosylase 1 |
| P70S6K | 70 kDa ribosomal protein S6 kinase |
| PARP | Poly(ADP-ribose) polymerase |
| Pb | Lead |
| PD-L1 | Programmed death-ligand 1 |
| PI3K | Phosphoinositide 3-kinase |
| PRKN | Parkin RBR E3 ubiquitin protein ligase |
| PTEN | Phosphatase and tensin homolog |
| p38 MAPK | p38 mitogen-activated protein kinase |
| p53 | Tumor protein p53 |
| p21 | Cyclin-dependent kinase inhibitor 1A |
| RB1 | RB transcriptional corepressor 1 |
| RAS | Rat sarcoma viral oncogene homolog |
| RAF | Rapidly accelerated fibrosarcoma kinase |
| RON | Recepteur d’origine nantais (macrophage-stimulating 1 protein receptor) |
| ROS | Reactive oxygen species |
| RTK | Receptor tyrosine kinase |
| SCLC | Small-cell lung cancer |
| SOD2 | Superoxide dismutase 2 |
| SOX2 | SRY-box transcription factor 2 |
| STAT3 | Signal transducer and activator of transcription 3 |
| STAT6 | Signal transducer and activator of transcription 6 |
| TGF-β | Transforming growth factor beta |
| TLR4 | Toll-like receptor 4 |
| TNF | Tumor necrosis factor |
| TP53 | Tumor protein p53 |
| VEGF | Vascular endothelial growth factor |
| VEGFA | Vascular endothelial growth factor A |
| VEGFR | Vascular endothelial growth factor receptor |
| WHO | World Health Organization |
| (GT)n | Guanine–thymine dinucleotide repeat |